Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome

A. Žák, M. Jáchymová, M. Burda, B. Staňková, M. Zeman, A. Slabý, M. Vecka, O. Šeda

. 2022 ; 12 (6) : . [pub] 20220620

Language English Country Switzerland

Document type Journal Article

Grant support
MH CZ DRO-VFN64165 the Ministry of Health of the Czech Republic
"Cooperatio - Gastroenterology" the Charles University Research program

Long-chain polyunsaturated fatty acids (LC-PUFAs) play important roles in human health, from controlling inflammation to lipid and glucose homeostasis. In our previous study, which employed a cluster analysis of a plasma fatty acid (FA) pattern, we identified two clusters of metabolic syndrome (MetS) independent of clinical and biochemical parameters within the whole study group (controls together with metabolic syndrome (MetS) patients). FA desaturase (FADS) genes are the key regulators of LC-PUFA metabolism. The aim of this study was to analyze associations between FADS polymorphisms and clusters of MetS. The study group consisted of 188 controls and 166 patients with MetS. The first cluster contained 71 controls (CON1) and 109 MetS patients (MetS1). The second cluster consisted of 117 controls (CON2) and 57 MetS patients (MetS2). In comparison with MetS2, cluster MetS1 displayed a more adverse risk profile. Cluster CON1 had, in comparison with CON2, higher body weight and increased triacylglycerol levels (p < 0.05). We found that the FADS rs174537 (p < 0.001), rs174570 (p < 0.01), and rs174602 (p < 0.05) polymorphisms along with two inferred haplotypes had statistically significant genotype associations with the splitting of MetS into MetS1 and MetS2. Conversely, we observed no significant differences in the distribution of FADS polymorphisms between MetS and CON subjects, or between CON1 and CON2. These associations between FADS polymorphisms and two clusters of MetS (differing in waist circumference, HOMA-IR, lipolysis, and oxidative stress) implicate the important influence of genetic factors on the phenotypic manifestation of MetS.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22016958
003      
CZ-PrNML
005      
20220720100041.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/metabo12060568 $2 doi
035    __
$a (PubMed)35736500
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Žák, Aleš $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
245    10
$a FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome / $c A. Žák, M. Jáchymová, M. Burda, B. Staňková, M. Zeman, A. Slabý, M. Vecka, O. Šeda
520    9_
$a Long-chain polyunsaturated fatty acids (LC-PUFAs) play important roles in human health, from controlling inflammation to lipid and glucose homeostasis. In our previous study, which employed a cluster analysis of a plasma fatty acid (FA) pattern, we identified two clusters of metabolic syndrome (MetS) independent of clinical and biochemical parameters within the whole study group (controls together with metabolic syndrome (MetS) patients). FA desaturase (FADS) genes are the key regulators of LC-PUFA metabolism. The aim of this study was to analyze associations between FADS polymorphisms and clusters of MetS. The study group consisted of 188 controls and 166 patients with MetS. The first cluster contained 71 controls (CON1) and 109 MetS patients (MetS1). The second cluster consisted of 117 controls (CON2) and 57 MetS patients (MetS2). In comparison with MetS2, cluster MetS1 displayed a more adverse risk profile. Cluster CON1 had, in comparison with CON2, higher body weight and increased triacylglycerol levels (p &lt; 0.05). We found that the FADS rs174537 (p &lt; 0.001), rs174570 (p &lt; 0.01), and rs174602 (p &lt; 0.05) polymorphisms along with two inferred haplotypes had statistically significant genotype associations with the splitting of MetS into MetS1 and MetS2. Conversely, we observed no significant differences in the distribution of FADS polymorphisms between MetS and CON subjects, or between CON1 and CON2. These associations between FADS polymorphisms and two clusters of MetS (differing in waist circumference, HOMA-IR, lipolysis, and oxidative stress) implicate the important influence of genetic factors on the phenotypic manifestation of MetS.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jáchymová, Marie $u Institute of Clinical Chemistry and Laboratory Diagnostics, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Burda, Michal $u Institute for Research and Applications of Fuzzy Modeling, University of Ostrava, 701 03 Ostrava, Czech Republic $1 https://orcid.org/0000000241824407
700    1_
$a Staňková, Barbora $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Zeman, Miroslav $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Slabý, Adolf $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Vecka, Marek $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic $u Institute of Clinical Chemistry and Laboratory Diagnostics, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000232691817 $7 xx0076497
700    1_
$a Šeda, Ondřej $u Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 00 Prague, Czech Republic $1 https://orcid.org/0000000184985895 $7 xx0070901
773    0_
$w MED00193532 $t Metabolites $x 2218-1989 $g Roč. 12, č. 6 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35736500 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100037 $b ABA008
999    __
$a ind $b bmc $g 1816385 $s 1168200
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 6 $e 20220620 $i 2218-1989 $m Metabolites $n Metabolites $x MED00193532
GRA    __
$a MH CZ DRO-VFN64165 $p the Ministry of Health of the Czech Republic
GRA    __
$a "Cooperatio - Gastroenterology" $p the Charles University Research program
LZP    __
$a Pubmed-20220718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...